These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7178372)

  • 21. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 22. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
    Tuschy U; Szeszat S; Rindfleisch U
    Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 24. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
    Walker LA; Frölich JC
    J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 26. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of vasopressin on human memory functions.
    Weingartner H; Gold P; Ballenger JC; Smallberg SA; Summers R; Rubinow DR; Post RM; Goodwin FK
    Science; 1981 Feb; 211(4482):601-3. PubMed ID: 7455701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of the antidiuretic effects of Adiuretin-SD (DDAVP) and Pitressin Tannate in diabetes insipidus.
    Czakó L; Julesz J; László FA
    Int J Clin Pharmacol Biopharm; 1978 Jan; 16(1):10-3. PubMed ID: 631964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of vasopressin-sensitive diabetes insipidus in children with DDAVP].
    Gerards LJ; van Leeuwen EF; Donckerwolcke RA; Kuijten RH
    Ned Tijdschr Geneeskd; 1975 Aug; 119(33):1269-72. PubMed ID: 1165795
    [No Abstract]   [Full Text] [Related]  

  • 30. Uterine activity in diabetes insipidus.
    Akerlund M; Andersson KE; Bengtsson LP; Laudanski T
    Acta Obstet Gynecol Scand; 1977; 56(4):381-5. PubMed ID: 602706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
    Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
    J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recent progress in the diagnosis and treatment of diabetes insipidus].
    Kawakami S; Honda K; Ishikawa S; Saito T
    Nihon Rinsho; 1993 Oct; 51(10):2737-41. PubMed ID: 8254949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation by chlorpropamide of 1-deamino-8-D-arginine vasopressin-induced antidiuresis and stimulation of renal medullary adenylate cyclase and accumulation of adenosine 3',5'-monophosphate.
    Moses AM; Coulson R
    Endocrinology; 1980 Mar; 106(3):967-72. PubMed ID: 6243558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [(Na-K) ATPase activity and corticopapillary osmotic gradient in the kidney of rats with hereditary hypothalamic diabetes insipudus after administration of 1-deamino-8-arginine-vasopressin (DDAVP)].
    Michajlovskij N; Ponec J; Dzurba A; Lichardus B
    Bratisl Lek Listy; 1980 Jun; 73(6):741-8. PubMed ID: 6249465
    [No Abstract]   [Full Text] [Related]  

  • 36. DDAVP in treatment of vasopressin-sensitive diabetes insipidus.
    Ward MK; Fraser TR
    Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shortened duration of action of 1-deamino-8-D-arginine vasopressin (DDAVP) in patients with diabetes insipidus requiring high doses of peroral antidiuretic drugs.
    Radó JP; Marosi J; Fischer J
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):518-24. PubMed ID: 789414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
    Tuschy U; Szeszat S; Meinhold J
    Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus.
    Kobrinsky NL; Doyle JJ; Israels ED; Winter JS; Cheang MS; Walker RD; Bishop AJ
    Lancet; 1985 Jun; 1(8441):1293-4. PubMed ID: 2860491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.